CYP7B1
Cytochrome P450 7B1
Also known as: CP7B1_HUMAN, SPG5A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75881
- Gene
- CYP7B1
- Ensembl
- ENSG00000172817
- Chromosome
- 8
- Canonical length
- 506 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway of extrahepatic tissues, which converts cholesterol to bile acids. This enzyme likely plays a minor role in total bile acid synthesis, but may also be involved in the development of atherosclerosis, neurosteroid metabolism and sex hormone synthesis. Mutations in this gene have been associated with hereditary spastic paraplegia (SPG5 or HSP), an autosomal recessive disorder. [provided by RefSeq, Apr 2016]
Canonical amino-acid sequenceUniProt
506 residues, UniProt reviewed canonical sequence.
>O75881|CYP7B1
1 MAGEVSAATG RFSLERLGLP GLALAAALLL LALCLLVRRT RRPGEPPLIK GWLPYLGVVL
61 NLRKDPLRFM KTLQKQHGDT FTVLLGGKYI TFILDPFQYQ LVIKNHKQLS FRVFSNKLLE
121 KAFSISQLQK NHDMNDELHL CYQFLQGKSL DILLESMMQN LKQVFEPQLL KTTSWDTAEL
181 YPFCSSIIFE ITFTTIYGKV IVCDNNKFIS ELRDDFLKFD DKFAYLVSNI PIELLGNVKS
241 IREKIIKCFS SEKLAKMQGW SEVFQSRQDV LEKYYVHEDL EIGAHHLGFL WASVANTIPT
301 MFWAMYYLLR HPEAMAAVRD EIDRLLQSTG QKKGSGFPIH LTREQLDSLI CLESSIFEAL
361 RLSSYSTTIR FVEEDLTLSS ETGDYCVRKG DLVAIFPPVL HGDPEIFEAP EEFRYDRFIE
421 DGKKKTTFFK RGKKLKCYLM PFGTGTSKCP GRFFALMEIK QLLVILLTYF DLEIIDDKPI
481 GLNYSRLLFG IQYPDSDVLF RYKVKSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP7B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- liver: 20 nTPM
- thyroid gland: 11 nTPM
- parathyroid gland: 11 nTPM
- spleen: 8.6 nTPM
- spinal cord: 8.4 nTPM
- adipose tissue: 7.9 nTPM
Single-cell type
- choroid plexus epithelial cells: 286 nCPM
- pituicytes/fscs: 172 nCPM
- fibro-adipogenic progenitors: 167 nCPM
- astrocytes: 141 nCPM
- gonadotrophs: 135 nCPM
- pericytes: 134 nCPM
Immune cell
- basophil: 2.5 nTPM
- eosinophil: 1.5 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- white matter: 61 nTPM
- medulla oblongata: 31 nTPM
- basal ganglia: 29 nTPM
- pons: 25 nTPM
- choroid plexus: 24 nTPM
- spinal cord: 24 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CYP7B1.
Disease | AllUniProt
Conditions CYP7B1 is implicated in, by any mechanism.
- Spastic paraplegia 5A, autosomal recessive (SPG5A) MIM:270800
- Congenital bile acid synthesis defect 3 (CBAS3) MIM:613812
Disease | GeneticClinVar
82 pathogenic / likely-pathogenic of 612 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spastic paraplegia
- Hereditary spastic paraplegia 5A
- Congenital bile acid synthesis defect 3
- Hereditary spastic paraplegia
- CYP7B1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.39
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell chemotaxis
- bile acid biosynthetic process
- cholesterol homeostasis
- cholesterol metabolic process
- epithelial cell proliferation
- estrogen receptor signaling pathway
- negative regulation of intracellular estrogen receptor signaling pathway
- positive regulation of epithelial cell proliferation
- prostate gland epithelium morphogenesis
- steroid biosynthetic process
- sterol metabolic process
Molecular functions
- 24S-hydroxycholesterol 7-alpha-hydroxylase activity
- heme binding
- iron ion binding
- oxysterol 7-alpha-hydroxylase activity
- steroid hydroxylase activity
- 25-hydroxycholesterol 7-alpha-hydroxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP7B1 as an antibody target. Whether an autoantibody or antibody against CYP7B1 could matter depends on whether native CYP7B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP7B1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP7B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...